Works by ter Heine, Rob

Results: 100
    1
    2
    3
    4
    5

    High unbound flucloxacillin fraction in critically ill patients.

    Published in:
    2021
    By:
    • Wallenburg, Eveline;
    • Heine, Rob ter;
    • Lange, Dylan W de;
    • Leeuwen, Henk van;
    • Schouten, Jeroen A;
    • Oever, Jaap ten;
    • Kolwijck, Eva;
    • Burger, David M;
    • Pickkers, Peter;
    • Gieling, Emilie M;
    • Maat, Monique M de;
    • Frenzel, Tim;
    • Brüggemann, Roger J;
    • Ter Heine, Rob;
    • de Lange, Dylan W;
    • van Leeuwen, Henk;
    • Ten Oever, Jaap;
    • de Maat, Monique M
    Publication type:
    journal article
    6
    7

    The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 4, p. 324, doi. 10.1016/j.cllc.2025.03.010
    By:
    • Kicken, Mart P.;
    • Heine, Rob Ter;
    • Azarfane, Intissar;
    • de Rouw, Nikki;
    • de Vries, Fenna;
    • Peters, Bas J. M.;
    • Lankheet, Nienke A. G.;
    • Eektimmerman, Frank;
    • Beerden, Tim;
    • Franssen, Eric J. F.;
    • Krens, Lisanne L.;
    • van der Leest, Cor H.;
    • Smit, Arthur A. J.;
    • Polman, Albert J.;
    • Vermeer, Laura C.;
    • van Putten, John W. G.;
    • van den Borne, Ben E. E. M.;
    • van den Heuvel, Michel M.;
    • Deenen, Maarten J.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Incidence and risk factors for nevirapine-associated rash.

    Published in:
    European Journal of Clinical Pharmacology, 2003, v. 59, n. 5/6, p. 457, doi. 10.1007/s00228-003-0613-3
    By:
    • de Maat, Monique M. R.;
    • ter Heine, Rob;
    • Mulder, Jan W.;
    • Meenhorst, Pieter L.;
    • Mairuhu, Albert T. A.;
    • van Gorp, Eric C. M.;
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8
    By:
    • Moes, Dirk J. A. R.;
    • Hendrikx, Jeroen J. M. A.;
    • Guchelaar, Henk-Jan;
    • Mathijssen, Ron H. J.;
    • Bakker, J. L.;
    • Dezentjé, Vincent O.;
    • de Rouw, Nikki;
    • van Erp, Nielka P.;
    • Smit, Egbert F.;
    • van den Heuvel, Michel M.;
    • Munnink, Thijs H. Oude;
    • van Kats, Maartje;
    • Croes, Sander;
    • Kroep, Judith R.;
    • Zwaveling, Juliette;
    • ter Heine, Rob
    Publication type:
    Article
    21

    A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6
    By:
    • ter Heine, Rob;
    • van den Heuvel, Michel M.;
    • Piet, Berber;
    • Deenen, Maarten J.;
    • van der Wekken, Anthonie J.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van Geel, Robin M. J. M.;
    • Jansman, Frank G. A.;
    • Boshuizen, Rogier C.;
    • Franssen, Eric J. F.;
    • Smit, Arthur A. J.;
    • Dumoulin, Daphne W.;
    • Oude Munnink, Thijs H.;
    • Smit, Egbert F.;
    • Derijks, Hieronymus J.;
    • van der Leest, Cor H.;
    • Hendrikx, Jeroen J. M. A.;
    • Moes, Dirk J. A. R.;
    • de Rouw, Nikki
    Publication type:
    Article
    22
    23

    Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry

    Published in:
    Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 15, p. 2505, doi. 10.1002/rcm.3119
    By:
    • ter Heine, Rob;
    • Alderden-Los, Carolien G.;
    • Rosing, Hilde;
    • Hillebrand, Michel J. X.;
    • van Gorp, Eric C. M.;
    • Huitema, Alwin D. R.;
    • Beijnen, Jos H.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.

    Published in:
    2020
    By:
    • ten Doesschate, Thijs;
    • Moorlag, Simone J. C. F. M.;
    • van der Vaart, Thomas W.;
    • Taks, Esther;
    • Debisarun, Priya;
    • ten Oever, Jaap;
    • Bleeker-Rovers, Chantal P.;
    • Verhagen, Patricia Bruijning;
    • Lalmohamed, Arief;
    • ter Heine, Rob;
    • van Crevel, Reinout;
    • van de Wijgert, Janneke;
    • Janssen, Axel B.;
    • Bonten, Marc J.;
    • van Werkhoven, Cornelis H.;
    • Netea, Mihai G.;
    • BCG-CORONA study team#
    Publication type:
    journal article
    32

    Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.

    Published in:
    2020
    By:
    • Ten Doesschate, Thijs;
    • Moorlag, Simone J C F M;
    • van der Vaart, Thomas W;
    • Taks, Esther;
    • Debisarun, Priya;
    • Ten Oever, Jaap;
    • Bleeker-Rovers, Chantal P;
    • Verhagen, Patricia Bruijning;
    • Lalmohamed, Arief;
    • Ter Heine, Rob;
    • van Crevel, Reinout;
    • van de Wijgert, Janneke;
    • Janssen, Axel B;
    • Bonten, Marc J;
    • van Werkhoven, Cornelis H;
    • Netea, Mihai G;
    • BCG-CORONA study team#
    Publication type:
    Letter
    33

    Model-informed development of a cost-saving dosing regimen for enfortumab vedotin.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2025, v. 95, n. 1, p. 1, doi. 10.1007/s00280-025-04764-x
    By:
    • Op 't Hoog, Catharina JP;
    • Rieborn, Amy;
    • Moes, Dirk Jan AR;
    • Hendrikx, Jeroen JMA;
    • van der Heijden, Michiel S.;
    • Franken, Mira D.;
    • van der Hulle, Tom;
    • van Kruchten, Michel;
    • Willemsen, Annelieke ECAB;
    • Koolen, Stijn LW;
    • Boerrigter, Emmy;
    • ter Heine, Rob
    Publication type:
    Article
    34
    35

    Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 33, doi. 10.1007/s00280-022-04489-1
    By:
    • de Rouw, Nikki;
    • Boosman, René J.;
    • Burgers, Jacobus A.;
    • Huitema, Alwin D. R.;
    • Dingemans, Anne-Marie C.;
    • Derijks, Hieronymus. J.;
    • Burger, David M.;
    • Piet, Berber;
    • Hendriks, Lizza E. L.;
    • Biesma, Bonne;
    • Pruis, Melinda A.;
    • Dumoulin, Daphne W.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • van den Heuvel, Michel M.;
    • ter Heine, Rob
    Publication type:
    Article
    36
    37
    38
    39

    Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136221
    By:
    • Meertens, Marinda;
    • Muntinghe-Wagenaar, M. Benthe;
    • Sikkema, Barend J.;
    • Lopez-Yurda, Marta;
    • Retèl, Valesca P.;
    • Paats, Marthe S.;
    • Heine, Rob Ter;
    • Schuuring, Ed;
    • Timens, Wim;
    • Touw, Daan J.;
    • van Boven, Job F. M.;
    • de Langen, Adrianus. J.;
    • Hashemi, Sayed M. S.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van den Heuvel, Michel M.;
    • Dingemans, Anne-Marie C.;
    • Mathijssen, Ron H. J.;
    • Smit, Egbert F.;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    A multicomponent intervention program to Prevent and Reduce AgItation and phySical rEstraint use in the ICU (PRAISE): study protocol for a multicenter, stepped-wedge, cluster randomized controlled trial.

    Published in:
    Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07807-x
    By:
    • Kooken, Rens W. J.;
    • Tilburgs, Bram;
    • ter Heine, Rob;
    • Ramakers, Bart;
    • van den Boogaard, Mark;
    • Wiggelo-Lijbers, Dieke;
    • Klop-Riehl, Margreet;
    • Rettig, Thijs C.D.;
    • Wijnhoven, JanWillem;
    • Simons, Bram;
    • van de Weyer, Rens;
    • Bakker, Stephanie;
    • de Ruijter, Wouter;
    • Slot, Stefanie;
    • Braker-Scholtes, Stefanie;
    • Bruin, Liz;
    • Habes, Quirine;
    • Meeuws, Sanne;
    • Fleuren-Janssen, Manon
    Publication type:
    Article
    46
    47
    48
    49
    50